Picture of Oncolytics Biotech logo

ONCY — Oncolytics Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Brief: Oncolytics announces phase 1b study in advanced pancreatic cancer

Oct 20 (Reuters) - Oncolytics Biotech Inc  ONC.TO : 
 * Biotech inc. announces phase 1b study in advanced pancreatic cancer 
 * Following submission to FDA, investigational new drug application is now 
   active 
 
 * Source text for Eikon  ID:nPn8yMKtH  
 
 * Further company coverage  ONC.TO  ((Bengaluru Newsroom; +1 646 223 8780))

Recent news on Oncolytics Biotech

See all news